“`html Oral PCSK9 Inhibitor Shows Promise in Lowering LDL-C Oral PCSK9 Inhibitor Shows Promise in Lowering LDL-C In the randomized, double-blind, placebo-controlled, phase 3 coralreef Lipids (NCT05952856) clinical trial, enlicitide …
Tag: